Feasibility of an Oral Intervention for Sexual Health in Transgender Men

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

November 21, 2024

Study Completion Date

November 21, 2024

Conditions
Vaginal DysbiosisVaginal DiseaseMolecular-bacterial Vaginosis
Interventions
DIETARY_SUPPLEMENT

Probiotic Group

The intervention is a mixture of two probiotics: 1) Lactobacillus acidophilus GLA-14 and 2) Lactobacillus rhamnosus HN001. These products will be combined into a single capsule/sachet with a dose of approximately 10\^10 colony forming units (CFUs) of GLA-14 (ATCC SD5212) and HN001 (ATCC SD5675) in a 4:1 ratio, using similar doses as recent studies using this product.

DIETARY_SUPPLEMENT

Placebo Group

The placebo will of be Maltodextrin, a carbohydrate, packaged similarly to the intervention and having the same weight.

Trial Locations (1)

11201

Callen-Lorde Community Health Center (CLCHC), Brooklyn

All Listed Sponsors
collaborator

Callen-Lorde Community Health Center

OTHER

lead

Columbia University

OTHER

NCT06470906 - Feasibility of an Oral Intervention for Sexual Health in Transgender Men | Biotech Hunter | Biotech Hunter